Unproven value of end-of-treatment and serial follow-up FDG-PET in primary mediastinal B-cell lymphoma

Autor: Hugo J.A. Adams, Thomas C. Kwee

Publikováno v: Haematologica, Vol 103, Iss 8 (2018)

Externí odkaz: https://doaj.org/article/6cac1aeeda3746f2b714f070bea65077

Inability of Fluorodeoxyglucose Positron Emission Tomography to Detect Viable Hodgkin Lymphoma During and After Treatment.

Autor: Adams HJA; Hugo J.A. Adams, MD, PhD, Department of Radiology and Nuclear Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands; and Thomas C. Kwee, MD, PhD, Department of Radiology, Nuclear Medicine, and Molecular Imaging, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., Kwee TC; Hugo J.A. Adams, MD, PhD, Department of Radiology and Nuclear Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands; and Thomas C. Kwee, MD, PhD, Department of Radiology, Nuclear Medicine, and Molecular Imaging, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.

Publikováno v: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2020 Apr 01; Vol. 38 (10), pp. 1115-1116. Date of Electronic Publication: 2020 Jan 30.

A 73% Price Reduction Does Not Indisputably Justify Routine Application of Brentuximab Vedotin as First-Line Treatment of Hodgkin Lymphoma.

Autor: Adams HJA; Hugo J.A. Adams, MD, PhD, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, the Netherlands; and Thomas C. Kwee, MD, PhD, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., Kwee TC; Hugo J.A. Adams, MD, PhD, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, the Netherlands; and Thomas C. Kwee, MD, PhD, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.

Publikováno v: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2019 Apr 01; Vol. 37 (10), pp. 852-853. Date of Electronic Publication: 2019 Feb 11.

Unproven Clinical Value of Interim FDG-PET in Aggressive Non-Hodgkin Lymphoma.

Autor: Adams HJA; Hugo J.A. Adams, Amsterdam UMC, Amsterdam, the Netherlands; and Thomas C. Kwee, Universitair Medisch Centrum Groningen, Groningen, the Netherlands., Kwee TC; Hugo J.A. Adams, Amsterdam UMC, Amsterdam, the Netherlands; and Thomas C. Kwee, Universitair Medisch Centrum Groningen, Groningen, the Netherlands.

Publikováno v: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2018 Nov 10; Vol. 36 (32), pp. 3271-3272. Date of Electronic Publication: 2018 Sep 17.

Interim Fluorodeoxyglucose Positron Emission Tomography-Adapted Therapy Is Not an Efficient Approach to Improving Outcome in Early-Stage Hodgkin Lymphoma.

Autor: Adams HJA; Hugo J.A. Adams, Deventer Ziekenhuis, Deventer, the Netherlands; and Thomas C. Kwee, University Medical Center Groningen, Groningen, the Netherlands., Kwee TC; Hugo J.A. Adams, Deventer Ziekenhuis, Deventer, the Netherlands; and Thomas C. Kwee, University Medical Center Groningen, Groningen, the Netherlands.

Publikováno v: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2017 Aug 20; Vol. 35 (24), pp. 2850-2851. Date of Electronic Publication: 2017 Jul 06.